Introduction
We explain intra-tumor heterogeneity by representing tumor cell populations as a mixture of subclones. We reconstruct unobserved subclones by utilizing information from pairs of proximal mutations that are obtained from next-generation sequencing (NGS) data. We exploit the fact that some short reads in NGS data cover pairs of phased mutations that reside on two sufficiently proximal loci. Therefore haplotypes of the mutation pairs can be observed and used for subclonal inference.
We develop a suitable sampling model that represents the paired nature of the data, and construct a nonparametric Bayesian feature allocation model as a prior for the hypothetical subclones. Both models together allow us to develop a fully probabilistic description of the composition of the tumor as a mixture of homogeneous underlying subclones, including the genotypes and number of such subclones.
Background
NGS technology (Mardis, 2008) has enabled researchers to develop bioinformatics tools that are being used to understand the landscape of tumors within and across different samples. An important related task is to reconstruct cellular subpopulations in one or more tumor samples, known as subclones. Mixtures of such subclones with varying population frequencies across spatial locations in the same tumor, across tumors from different time points, or across tumors from the primary and metastatic sites can provide information about the mechanisms of tumor evolution and metastasis. Heterogeneity of cell populations is seen, for example, in varying frequencies of distinct somatic mutations.
The hypothetical tumor subclones are homogeneous. That is, a subclone is characterized by unique genomic variants in its genome (Marjanovic et al., 2013; Almendro et al., 2013; Polyak, 2011; Stingl and Caldas, 2007; Shackleton et al., 2009; Dexter et al., 1978) .
Such subclones arise as the result of cellular evolution, which can be described by a phylogenetic tree that records how a sequence of somatic mutations gives rise to different cell subpopulations. We use NGS data to infer such tumor heterogeneity. In an NGS experiment, DNA fragments are first produced by extracting the DNA molecules from the cells in a tumor sample. The fragments are then sequenced using short reads. For the three subclones in Figure 1 (a), there are four aforementioned haplotypes at the three loci. Consequently, short reads that cover some of these three loci may manifest different alleles. For example, if a large number of reads cover the first two loci, we might observe (A, G), (C, G), (A, T) and (C, T), four alleles for the mutation pair. Observing four alleles is direct evidence supporting the presence of subclones (Sengupta et al., 2015) . This is because, in the absence of copy number variations there can be only two haploid genomes at any loci for a homogeneous human sample. Therefore, one can use mutation pairs in copy neutral regions to develop statistical inference on the presence and frequency of subclones. This is the goal of our paper.
Almost all mutation-based subclone-calling methods in the literature use only single nucleotide variants (SNVs) (Oesper et al., 2013; Strino et al., 2013; Jiao et al., 2014; Miller et al., 2014; Roth et al., 2014; Zare et al., 2014; Deshwar et al., 2015; Sengupta et al., 2015; Lee et al., 2015 Lee et al., , 2016 . Instead of examining mutation pairs, SNV-based methods use marginal counts for each recorded locus only. Consider, for example, the first locus in Figure 1 (a). At this locus, the reference genome has an "A" nucleotide while subclones 2 and 3 have a "C" nucleotide. In the entire sample, the "C" nucleotide is roughly present in 17.5% of the DNA molecules based on the population frequencies illustrated in Figure 1 (a). The percentage of a mutated allele is called variant allele fraction (VAF). If a sample is homogeneous and assuming no copy number variations at the locus, the population frequency for the "C" nucleotide should be close to 0, 50%, or 100%, depending on the heterozygosity of the locus. Therefore, if the population frequency of "C" deviates from 0%, 50%, or 100%, the sample is likely to be heterogeneous. Based on this argument, SNV-based subclone callers search for SNVs with VAFs that are different from these frequencies (0, 50%, 100%), which are evidence for the presence of different (homogeneous) subpopulations. In the event of copy number variations, a similar but slightly more sophisticated reasoning can be applied, see for example, Lee et al. (2016) .
Using mutation pairs
NGS data usually contain substantially fewer mutation pairs than marginal SNVs. However, this does not weaken the power of using mutation pairs as mutation pairs naturally carry important phasing information that improves the accuracy of subclone reconstruction. For example, imagine a tumor sample that is a mixture of subclones 2 and 3 in (a) Tumor evolution The reference genome for mutation pair 2 is (G, T) and the corresponding genotype of subclone 1 is ((G, C), (A, C)), which gives rise to z 21 = ((0, 1), (1, 1)). (c) Illustration of paired-end reads data for a mutation pair. Shown are four short reads mapped to mutation pair k in sample t. Some reads are mapped to both loci of the mutation pair, and others are mapped to only one of the two loci. The two ends of the same read are marked with opposing arrows in purple and orange.
Figure 1(a). Suppose a sufficient amount of short reads cover the first two loci, we should observe relatively large reads counts for four alleles (C, G), (A, T), (C, T) and (A, G).
One can then reliably infer that there are heterogeneous cell subpopulations in the tumor sample. In contrast, if we ignore the phasing information and only consider the (marginal) VAFs for each SNV, then the observed VAFs for both SNVs are 50%, which could be heterogeneous mutations from a single cell population. See Simulation 1 for an illustration. In summary, we leverage the power of using mutation pairs over marginal SNVs by incorporating partial phasing information in our model. Besides the simulation study we will later also empirically confirm these considerations in actual data analysis.
The relative advantage of using mutation pairs over marginal SNV's can be also be understood as a special case of a more general theme. In biomedical data it is often important to avoid overinterpretation of noisy data and to distill a relatively weak signal.
A typical example is the probability of expression (POE) model of Parmigiani et al. (2002) . Similarly, the modeling of mutation pairs is a way to extract the pertinent information from the massive noisy data. Due to noise and artifact in NGS data, such as base-calling or mapping error, many called SNVs might record unusual population frequencies, for reasons unrelated to the presence of subclones (Li, 2014) . Direct modeling of all marginal read counts one ends up with noise swamping the desired signal (NikZainal et al., 2012; Jiao et al., 2014) . See our analysis of a real data set in Section 6 for an example. To mitigate this challenge, most methods use clustering of the VAFs, including, for example, Roth et al. (2014) . One would then use the resulting cluster centers to infer subclones, which is one way of extracting more concise information. In addition, the vast majority of the methods in the literature show that even though a tumor sample could possess thousands to millions of SNVs, the number of inferred subclones usually is in the low single digit, no more than 10. To this end, we propose instead an alternative approach to extract useful information by modeling (fewer) mutation pairs, as mutation pairs contain more information and are of higher quality. We show in our numerical examples later that with a few dozens of these mutation pairs, the inference on the subclones is strikingly similar to cluster-based subclone callers using much more SNVs.
Finally, using mutation pairs does not exclude the possibility of making use of marginal SNVs. In Section 5.1, we show it is straightforward to jointly model mutation pairs and SNVs. Other biological complexities, such as tumor purity and copy number variations, can also be incorporated in our model. See Sections 5.2 and 5.3 for more details.
Representation of subclones
We construct a K ×C categorical valued matrix Z (Figure 1(b) ) to represent the subclone structure. Rows of Z are indexed by k and represent mutation pairs, and a column of Z, denoted by z c = (z 1c , · · · , z Kc ), records the phased mutation pairs on the two homologous chromosomes of subclone c, c = 1, . . . , C. As in Figure 1 (b), let j = 1, 2 index the two homologous chromosomes, r = 1, 2 index the two mutation loci, z kc = (z kcj , j = 1, 2) be the genotype consisting of two alleles for mutation pair k in subclone c, and z kcj = (z kcjr , r = 1, 2) denote the allele of the j-th homologous chromosome. Therefore, each entry z kc of the matrix Z is a 2 × 2 binary submatrix itself. For example, in Figure 1 (b) the entry z 21 is a pair of 2-dimension binary row vectors, (0, 1) and (1, 1), representing the genotypes for both alleles at mutation pair k = 2 of subclone c = 1; each vector indicates the allele for the mutation pair on a homologous chromosome. The first vector (0, 1) indicates that locus r = 1 harbors no mutation (0) and locus r = 2 harbors a mutation (1). Similarly, the second vector (1, 1) marks two mutations on both loci.
In summary, each entry of Z,
is a 2 × 2 matrix (with the two row vectors horizontally displayed for convenience). Each z kcjr is a binary indicator and z kcjr = 1 (or 0) indicates a mutation (or reference). Thus, z kc can take Q = 16 possible values. That is, z kc ∈ {z
(1) , . . . , z (16) } = {(00, 00), (00, 01),
. . . , (11, 11)}, where we write 00 short for (0, 0) etc., and z (1) = (00, 00) refers to the genotype on the reference genome. Formally, z kc is a 2 × 2 binary matrix, and Z is a matrix of such binary matrices. Moreover, we can collapse some z (q) values as we do not have phasing across mutation pairs. For example, z kc = (01, 10) and z kc = (10, 01), etc. have mirrored rows and are indistinguishable in defining a subclone (a column of Z). (More details in Section 2.2). Typically distinct mutation pairs are distant from each other, and in NGS data they are almost never phased. Therefore, we can reduce the number of possible outcomes of z kc to Q = 10, due to the mirrored outcomes. We list them below for later reference: z (1) = (00, 00), z (2) = (00, 01), z (3) = (00, 10), z (4) = (00, 11), z (5) = (01, 01), z (6) = (01, 10), z (7) = (01, 11), z (8) = (10, 10), z (9) = (10, 11) and z (10) = (11, 11). In summary, the entire matrix Z fully specifies the genomes of each subclone at all the mutation pairs.
Suppose T tumor samples are available from the same patient, obtained either at different time points (such as initial diagnosis and relapses), at the same time but from different spatial locations within the same tumor, or from tumors at different metastatic sites. We assume those T samples share the same subclones, while the subclonal population frequencies may vary across samples. For clinical decisions it can be important to know the population frequencies of the subclones. To facilitate such inference, we introduce a T × (C + 1) matrix w to represent the population frequencies of subclones.
The element w tc refers to the proportion of subclone c in sample t, where 0 < w tc < 1 for all t and c, and C c=0 w tc = 1. A background subclone, which has no biological meaning and is indexed by c = 0, is included to account for artifacts and experimental noise. We will discuss more about this later.
The remainder of this article is organized as follows. In Sections 2 and 3, we propose a Bayesian feature allocation model and the corresponding posterior inference scheme to estimate the latent subclone structure. In Section 4, we evaluate the model with three simulation studies. Section 5 extends the models to accommodate other biological complexities and present additional simulation results. Section 6 reports the analysis results for a lung cancer patient with multiple tumor biopsies. We conclude with a final discussion in Section 7.
The PairClone Model

Sampling Model
Suppose paired-end short reads data are obtained by deep DNA sequencing of multiple tumor samples. In such data, a short read is obtained by sequencing two ends of the same DNA fragment. Usually a DNA fragment is much longer than a short read, and the two ends do not overlap and must be mapped separately. However, since the paired-end reads are from the same DNA fragment, they are naturally phased and can be used for inference of alleles and subclones. We use LocHap (Sengupta et al., 2015) to find pairs of mutations that are no more than a fixed number, say 500, base pairs apart. Such mutation pairs can be mapped by paired-end reads, making them eligible for PairClone analysis. See Figure 1 (c) for an example. For each mutation pair, a number of short reads are mapped to at least one of the two loci. Denote the two sequences on short read i mapped to mutation pair k in tissue sample t by s
tk2 , where r = 1, 2 index the two loci, s (i) tkr = 0 or 1 indicates that the short read sequence is a reference or mutation. Theoretically, each s (i) tkr can take four values, A, C, G, T, the four nucleotide sequences. However, at a single locus, the probability of observing more than two sequences across short reads is negligible since it would require the same locus to be mutated twice throughout the life span of the person or tumor, which is unlikely. We therefore code s
tkr as a binary value. Also, sometimes a short read may cover only one of the two loci in a pair, and we use s (i) tkr = − to represent a missing base when there is no overlap between a short read and the corresponding SNV. Therefore,
tkr ∈ {0, 1, −}. For example, in Figure 1 (c) locus r = 1, s
(1) tk1 = 0 for read i = 1, s (2) tk1 = 1 for read i = 2, and s (3) tk1 = − for read i = 3. Reads that are not mapped to either locus are excluded from analysis since they do not provide any information for subclones.
Altogether, s (i)
tk can take G = 8 possible values, and its sample space is denoted by H = {h 1 , . . . , h G } = {00, 01, 10, 11, −0, −1, 0−, 1−}. Each value corresponds to an allele of two loci, with − being a special "missing" coverage. For mutation pair k in sample t, the number of short reads bearing allele h g is denoted by n tkg = i I s (i) tk = h g , where I(·) is the indicator function, and the total number of reads mapped to the mutation pair is then N tk = g n tkg . Finally, depending upon whether a read covers both loci or only one locus we distinguish three cases: (i) a read maps to both loci (complete), taking values s (i) tk ∈ {h 1 , . . . , h 4 }; (ii) a read maps to the second locus only (left missing), s
tk ∈ {h 5 , h 6 }; and (iii) a read maps to the first locus only (right missing), s
We assume a multinomial sampling model for the observed read counts
Here p = {p tkg , g = 1, . . . , 8} are the probabilities for the 8 possible values of s
tk . For the upcoming discussion, we separate out the probabilities for the three missingness cases.
Let v tk1 , v tk2 , v tk3 denote the probabilities of observing a short read satisfying cases (i),
(ii) and (iii), respectively. We write p tkg = v tk1ptkg , g = 1, . . . , 4, p tkg = v tk2ptkg , g = 5, 6, and p tkg = v tk3ptkg , g = 7, 8. Herep tkg are the probabilities conditional on case (i),
(ii) or (iii). That is, 4 g=1p tkg = g=5,6p tkg = g=7,8p tkg = 1. We still use a single running index, g = 1, . . . , 8, to match the notation in p tkg . Below we link the multinomial sampling model with the underlying subclone structure by expressingp tkg in terms of Z and w. Regarding v tk1 , v tk2 , v tk3 we assume non-informative missingness and therefore do not proceed with inference on them (and v's remain constant factors in the likelihood).
Prior Model
Construction ofp tkg . The construction of a prior model forp tkg is based on the following generative model. To generate a short read, we first select a subclone c from which the read arises, using the population frequencies w tc for sample t. Next we select with probability 0.5 one of the two DNA strands, j = 1, 2. Finally, we record the read h g , g = 1, 2, 3 or 4, corresponding to the chosen allele z kcj = (z kcj1 , z kcj2 ). In the case of left (or right) missing locus we observe h g , g = 5 or 6 (or g = 7 or 8), corresponding to the observed locus of the chosen allele. Reflecting these three generative steps, we denote the probability of observing a short read h g that bears sequence z kcj by
with the understanding that I(− = z kcjr ) ≡ 1 for missing reads. Implicit in (2) is the restriction A(h g , z kc ) ∈ {0, 0.5, 1}, depending on the arguments.
Finally, using the definition of A(·) we model the probability of observing a short read
In (3) we include w t0 ρ g to model a background subclone denoted by c = 0 with population frequency w t0 . The background subclone does not exist and has no biological interpretation. It is only used as a mathematical device to account for noise and artifacts in the NGS data (sequencing errors, mapping errors, etc.). The weights ρ g are the conditional probabilities of observing a short read s
tk harboring allele h g if the recorded read were due to experimental noise. Note that ρ 1 + . . . + ρ 4 = ρ 5 + ρ 6 = ρ 7 + ρ 8 = 1.
Prior for C. We assume a geometric distribution prior on C, C ∼ Geom(r), to describe the random number of subclones (columns of Z),
Prior for Z. We use the finite version of the categorical Indian buffet process (cIBP) (Sengupta et al., 2013) as the prior for the latent categorical matrix Z. The cIBP is a categorical extension of the Indian buffet process (Griffiths and Ghahramani, 2011) and defines feature allocation (Broderick et al., 2013) for categorical matrices. In our application, the mutation pairs are the objects, and the subclones are the latent features chosen by the objects. The number of subclones C is random, with the geometric prior p(C). Conditional on C, we now introduce for each column of Z vector π c = (π c1 , π c2 , . . . , π cQ ), where p(z kc = z (q) ) = π cq , and Q q=1 π cq = 1. Recall that z (q) are the possible genotypes for the mutation pairs defined in Section 1.3, q = 1, . . . , Q, for Q = 10 possible genotypes.
As prior model for π c , we use a Beta-Dirichlet distribution (Kim et al., 2012) . Let
distribution, and (π c2 , . . . ,π cQ ) ∼ Dir(γ 2 , . . . , γ Q ) follows a Dirichlet distribution. Here z kc = z (1) corresponds to the situation that subclone c is not chosen by mutation pair k, because z (1) refers to the reference genome. We write
This construction includes a positive probability for all-zero columns z c = 0. In our application, z c = 0 refers to normal cells with no somatic mutations, which could be included in the cell subpopulations.
In the definition of the cIBP prior, we would have one more step of dropping all zero columns. This leaves a categorical matrix Z with at most C columns. As shown in Sengupta et al. (2013) , the marginal limiting distribution of Z follows the cIBP as
Prior for w. We assume w t follows a Dirichlet prior,
for t = 1, · · · , T . We set d 0 < d to reflect the nature of c = 0 as a background noise and model mis-specification term.
Prior for ρ. We complete the model with a prior for ρ = {ρ g }. Recall ρ g is the conditional probability of observing a short read with allele h g due to experimental noise.
We consider complete read, left missing read and right missing read separately, and
where g 1 = {1, 2, 3, 4}, g 2 = {5, 6} and g 3 = {7, 8}.
Posterior Inference
Let x = (Z, π, w, ρ) denote the unknown parameters except C, where Z = {z kc }, π = {π cq }, w = {w tc }, and ρ = {ρ g }. We use Markov chain Monte Carlo (MCMC) simulations to generate samples from the posterior x
With fixed C such MCMC simulation is straightforward. See, for example, Brooks et al. (2011) for a review of MCMC. Gibbs sampling transition probabilities are used to update Z and π, and Metropolis-Hastings transition probabilities are used to update w and ρ. Since p(x | n, C) is expected to be highly multi-modal, we use additional parallel tempering to improve mixing of the Markov chain. Details of MCMC simulation and parallel tempering are described in Appendix A.1.
Updating C. Updating the value of C is more difficult as it involves trans-dimensional MCMC (Green, 1995) . At each iteration, we propose a new valueC by generating from a proposal distribution q(C | C). In the later examples we assume that C is a priori restricted to C min ≤ C ≤ C max , and use a uniform proposal q(C | C) ∼ Unif{C min , . . . , C max }.
Next, we split the data into a training set n and a test set n with n tkg = bn tkg and
posterior of x conditional on C evaluated on the training set only. We use p b in two instances. First, we replace the original prior p(x | C) by p b (x | C), and second, we use p b as a proposal distribution forx, as q(x |C) = p b (x |C). Finally, we evaluate the acceptance probability of (C,x) on the test data by
The use of the prior p b (x |C) is similar to the construction of the fractional Bayes factor (FBF) (O'Hagan, 1995) which uses a fraction of the data to define an informative prior that allows the evaluation of Bayes factors. In contrast, here p b is used as an informative proposal distribution forx. Without the use of a training sample it would be difficult to generate proposalsx with reasonable acceptance rate. In other words, we use p b to achieve a better mixing Markov chain Monte Carlo simulation. The use of the same p b to replace the original prior avoids the otherwise prohibitive evaluation of p b in the acceptance probability (4). See more details in Appendix A.2 and A.5.
Point estimates for parameters. We use the posterior modeĈ as a point estimate of C. Conditional onĈ, we follow Lee et al. (2015) to find a point estimate of Z. For any two K ×Ĉ matrices Z and Z , a distance between the c-th column of Z and the
, where 1 ≤ c, c ≤Ĉ, and we take the vectorized form of z kc and z kc to compute L 1 distance between them.
Then, we define the distance between Z and A posterior point estimate for Z, denoted byẐ, is reported asẐ = Z (l) , wherê
Based onl, we report posterior point estimates of w and ρ, given byŵ = w (l) and
Simulation
We evaluate the proposed model with three simulation studies. In the first simulation we use single sample data (T = 1), since in most current applications only a single sample is available for analysis. Inferring subclonal structure accurately under only one sample is a major challenge, and not completely resolved in the current literature. The single sample does not rule out meaningful inference, as the relevant sample size is the number of SNVs or mutation pairs, or the (even larger) number of reads. In the second and third simulations we consider multi-sample data, similar to the lung cancer data that we analyze later. In all simulations, we assume the missing probabilities v tk2 and v tk3 to be 30% or 35%. Recall that these probabilities represent the probabilities that a short read will only cover one of the two loci in the mutation pair.
Details of the three simulation studies are reported in Appendix A.3. We briefly summarize the results here. In the first simulation, we illustrate the advantage of using mutation pair data over marginal SNV counts. We generate hypothetical short reads data for T = 1 sample and K = 40 mutation pairs, using a simulation truth with C TRUE = 2. 5 PairClone Extensions
Incorporating Marginal Read Counts
Most somatic mutations are not part of the paired reads that we use in PairClone. We refer to these single mutations as SNVs (single nucleotide variants) and consider the following simple extension to incorporate marginal counts for SNVs in PairClone. We introduce a new S × C matrix Z S to represent the genotype of the C subclones for these additional SNVs. To avoid confusion, we denote the earlier K × C subclone matrix by model by recording them as right (or left) missing reads (as described in Section 2.1) for hypothetical pairs, k = K + 1, . . . , k + S. LetÑ ts andñ ts denote the total count and the number of reads bearing a variant allele, respectively, for SNV s in sample t.
Treating s as a mutation pair k = K + s with missing second read, we record n tk8 =ñ ts , n tk1 = . . . = n tk7 = 0 and N tk =Ñ ts . We then proceed as before, now with K + S mutation pairs. Inference reports an augmented (K + S) × C subclone matrixZ P . We record the first K rows ofZ P as Z P , and transform the remaining S rows to Z S by only recording the genotypes of the observed loci.
We evaluate the proposed modeling approach with a simulation study. The simulation setting is the same as simulation 3 in Section 4, except that we discard the phasing information of mutation pairs 51−100 and only record their marginal read counts. 
Incorporating Tumor Purity
Usually, tumor samples are not pure in the sense that they contain certain proportions of normal cells. Tumor purity refers to the fraction of tumor cells in a tumor sample. To explicitly model tumor purity, we introduce a normal subclone, the proportion of which in sample t is denoted by w t , t = 1, . . . , T . The normal subclone does not possess any mutation (since we only consider somatic mutations). The tumor purity for sample t is thus (1 − w t ). The normal subclone is denoted by z * , with z k * = z (1) for all k. The remaining subclones are still denoted by z c , c = 1, . . . , C, with proportion w tc in sample t, and C c=0 w tc + w t = 1. The probability model needs to be slightly modified to accommodate the normal subclone. The sampling model remains unchanged as (1). Same for the prior models for Z, ρ and C. We only change the construction ofp tkg and p(w) as follows.
With a new normal subclone, the probability of observing a short read h g becomes
(1) ) + w t0 ρ g , based on the same generative model described in Section 2.2. Letw tc = w tc /(1 − w t ). We use a Beta-Dirichlet prior,
). We evaluate the modified model with a simulation study. The simulation setting is the same as simulation 3 in Section 4, except that we substitute the first subclone with a normal subclone. Posterior inference (not shown) recovers the simulation truth, with posterior modeĈ = 2. Inference on Z almost perfectly recovers the simulation truth shown in Figure 2 (c) (with the first column replaced by an all normal "subclone").
Similarly for w. See Appendix A.4 for details.
Incorporating Copy Number Changes
Tumor cells not only harbor sequence mutations such as SNVs and mutation pairs, they often undergo copy number changes and produce copy number variants (CNVs). Genomic regions with CNVs have copy number = 2. We briefly outline an extension of PairClone that includes CNVs in the inference. In addition to Z which describes sequence variation we introduce a K × C matrix L to represent subclonal copy number variation with kc reporting the copy number for mutation pair k in subclone c. We use L to augment the sampling model to include the total read count N tk . Earlier in (1), the multinomial sample size N tk was considered fixed. We now add a sampling model. Following Lee et al. (2016) we assume
Here, φ t is the expected number of reads in sample t under copy-neutral conditions, and M tk is a weighted average copy number across subclones,
w tc kc + w t0 k0 .
The last term w t0 k0 accounts for noise and artifacts, where w t0 and k0 are the population frequency and copy number of the background subclone, respectively. We assume no
CNVs for the background subclone, that is, k0 = 2 for all k. We complete the model with a prior p(L). Assuming kc ∈ {0, . . . , Q}, i.e., a maximum copy number Q, we use another instance of a finite cIBP. For each column of L, we introduce π c = (π c0 , π c1 , . . . , π cQ ) and assume p( kc = q) = π cq , again with a Beta-Dirichlet prior for π c .
Recall the construction ofp tkg in (3), including in particular the generative model.
This generative model is now updated to include the varying tc . To generate a short read for mutation pair k, we first select a subclone c from which the read arises, using the population frequencies w tc kc / C c=0 w tc kc for sample t. Next we select with probability z kcj / kc one of the four possible alleles, h g , g = 1, 2, 3 or 4, where we now use z kc = (z kcj , j = 1, . . . , 4) to denote numbers of alleles having genotypes 00, 01, 10 or 11, and j z kcj = kc . In the case of left (or right) missing locus we observe h g , g = 5 or 6 (or g = 7 or 8), corresponding to the observed locus of the chosen allele, similar to before.
In summary, the probability of observing a short read h g can be written as
where A(·) corresponds to the described generative model.
Lung Cancer Data 6.1 Using PairClone
We apply PairClone to analyze whole-exome in-house data. Whole-exome sequencing data is generated from four (T = 4) surgically dissected tumor samples taken from a single patient diagnosed with lung adenocarcinoma. The resected tumor is divided into two portions. One portion is flash frozen and another portion is formalin fixed and paraffin embedded (FFPE At the end of this process, 69 mutation pairs are left and we record the read data from HCF files for the analysis. In addition, in the hope of utilizing more information from the data, we randomly choose 69 un-paired SNVs and include them in the analysis. Since in practice, tumor samples often include contamination with normal cells, we incorporate inference for tumor purity as described in Section 5.2. We run MCMC simulation for 30, 000 iterations, discarding the first 10, 000 iterations as initial burn-in and keeping every 10th MCMC sample. We set the hyperparameter exactly as in the simulation study of Section 5.2. 
Using SNVs only
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Conclusions
We can significantly enrich our understanding of cancer development by using high throughput NGS data to infer co-existence of subpopulations which are genetically dif- 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33 ferent across tumors and within a single tumor (inter and intra tumor heterogeneity, respectively). In this paper, we have presented a novel feature allocation model for reconstructing such subclonal structure using mutation pair data. Proposed inference explicitly models overlapping mutation pairs. We have shown that more accurate inference can be obtained using mutation pairs data compared to using only marginal counts for single SNVs. Short reads mapped to mutation pairs can provide direct evidence for heterogeneity in the tumor samples. In this way the proposed approach is more reliable than methods for subclonal reconstruction that rely on marginal variant allele fractions only.
The proposed model is easily extended for data where an LH segment consists of more than two SNVs. We can easily accommodate n-tuples instead of pairs of SNVs by increasing the number of categorical values (Q) that the entries in the Z matrix can take. There are several more interesting directions of extending the current model. For example, one could account for the potential phylogenetic relationship among subclones (i.e the columns in the Z matrix). Such extensions would enable one to infer mutational timing and allow the reconstruction of tumor evolutionary histories.
Lastly, we focus on statistical inference using bulk sequencing data on tumor samples.
Alternatively, biologists can apply single-cell sequencing on each tumor cell and study its genome one by one. This is a gold standard that can examine tumor heterogeneity at the single-cell level. However, single-cell sequencing is still expensive and cannot scale up. 
Appendix A A.1 MCMC Implementation Details
We first introduce θ tc as an unscaled abundance level of subclone c in sample t. Assume
We make inference on θ instead of w as the value of θ is not restricted in a C-simplex. Similarly, we introduce ρ * g as an unscaled version of ρ g . We let ρ * g ∼ Gamma(d 1 , 1) and ρ g = ρ * g / 4 g =1 ρ * g for g = 1, . . . , 4, ρ * g ∼ Gamma(2d 1 , 1) and ρ g = ρ * g / 6 g =5 ρ * g for g = 5, 6, and ρ * g ∼ Gamma(2d 1 , 1) and
Conditional on C, the posterior distribution for the other parameters is given by
where
) counts the number of mutation pairs in subclone c having genotype z (q) .
Updating Z. We update Z by sampling each z kc from:
Updating π. The posterior distribution for π is
For each c = 1, . . . , C, we update π c by sampling from
and transforming by (π c2 , . . . , π cQ ) = (1 − π c1 ) · (π c2 , . . . ,π cQ ).
Updating θ. We update each θ tc sequentially. For c = 1, . . . , C,
A Metropolis-Hastings transition probability is used to update θ tc . At each iteration, we propose a newθ tc (on the log scale) by log(θ tc ) ∼ N (log θ tc , 0.2), and evaluate the acceptance probability by
The term p(θ tc |θ tc )/p(θ tc | θ tc ) =θ tc /θ tc takes into account the Jacobian of the log transformation. For c = 0, the only difference is to substitute d with d 0 .
Updating ρ * . We update each ρ * g sequentially. For g = 1, . . . , 4,
A Metropolis-Hastings transition probability is used to update ρ * g . At each iteration, we propose a newρ * g (on the log scale) by log(ρ * g ) ∼ N (log ρ * g , 0.1), and evaluate the acceptance probability by
g takes into account the Jacobian of the log transformation. For g = 4, . . . , 8, the only difference is to substitute d 1 with 2d 1 . Geyer (1991) . A good review can be found in Liu (2008) . PT is suitable for sampling from a multi-modal state space. It helps the MCMC chain to move freely among local modes which is desired in our application, and to create a better mixing Markov chain.
Parallel tempering. Parallel tempering (PT) is a MCMC technique first proposed by
To sample from the target distribution π(x), we consider a family of distributions Π = {π i , i = 1, . . . , I}, where π i (x) ∝ π(x) 1/∆ i . Without loss of generality, let ∆ I = 1 and π I (x) = π(x). Denote by X i the state space of π i (x). The PT scheme is illustrated in Algorithm 1.
In our application, we find by simulation that PT works well with I = 10 temperatures and {∆ 1 , . . . , ∆ 10 } = {4.5, 3.2, 2.5, 2, 1.7, 1.5, 1.35, 1.2, 1.1, 1}. We therefore use this parameter setting for all the simulation studies as well as the lung cancer dataset.
A.2 Updating C
For updating C, we split the data into a training set n , and a test set n with n tkg = bn tkg i+1 , accept the swap with probability min 1, We evaluate the acceptance probability ofC on the test data by
Under the model p b (·) with the modified prior, the implied conditional posterior on x
which indicates the conditional posterior of x remains entirely unchanged. The implied
, with the likelihood on the test
is similar to the construction of the fractional Bayes factor (FBF) (O'Hagan, 1995) . Let u = {π, w, ρ} denote the parameters other than Z and let u * denote the maximum likelihood estimate for u. We follow O'Hagan (1995) to show that inference on C is as if we were making use of only a fraction (1 − b) of the data, with a dimension penalty. In short,
approximately, where u * is the maximum likelihood estimate of u, and p C is the number of unconstrained parameters in u. To obtain this approximation, consider the marginal sampling model under p b (·), after marginalizing with respect to x:
Here we substituted the training sample posterior as (new) prior p b (x | C). The integration includes a marginalization with respect to the discrete Z,
For the remaining real valued parameters u we use an appropriate one-to-one transformation (e.g. logit transformation) u →ũ, such thatũ is unconstrained. To simplify notation we continue to refer to the transformed parameter as u only. Next, under the
, Let m(n) and h b (n | C) denote the two factors. The first, m(n), is a constant term.
And the second factor, h b (n | C), has exactly the same form as equation (12) in O'Hagan (1995) , who shows
Let N = t,k N tk . The argument of Gelfand and Dey (1994) 
A.3 Simulation Studies and Comparison with Marginal Counts
We report details of the three simulation studies that are summarized in the manuscript (Section 4). The discussion includes a comparison with inference under methods that use only marginal mutation counts.
A.3.1 Simulation 1
Setup. In the first simulation, we illustrate the advantage of using mutation pair data over marginal SNV counts. We generate hypothetical short reads data for T = 1 sample and K = 40 mutation pairs. Based on our own experiences, for a whole-exome sequencing data set, we usually obtain dozens of mutation pairs with decent coverage. See Sengupta et al. (2015) (wild type) for mutation pairs 1-10 and 31 -40, and z (4) for mutation pairs 11-30. We generate ρ TRUE from its prior with hyperparameter d 1 = 1. Next we set the probabilities of observing left and right missing reads as v tk2 = v tk3 = 0.3 for all k and t, to mimic a typical missing rate observed in the real data. We calculate multinomial probabilities {p TRUE tkg } shown in equations (3) and (2) from the simulated Z TRUE , w TRUE and ρ TRUE .
Total read counts N tk are generated as random numbers ranging from 400 to 600, and finally we generate read counts n tkg from the multinomial distribution given N tk as shown in equation (1).
We fit the model with hyperparameters fixed as follows: Results. 35  55  49  44  28  47  33  48  59  30  23  27  36  39  53  57  56  60  38  22  29  21  34  37  25  3  17  12  78  79  70  71  72  73  74  75  76  77  9  7  5  1  80  18  19  16  13  10  11  14  15  8  6  4  2  20  69  68  67  66  65  64  63  62 The cellular prevalence is defined as fraction of clonal population harbouring a mutation.
In the PyClone MCMC samples, the estimated cellular prevalence of cluster 2 fluctuates between 0.5 and 1 and thus includes high posterior uncertainty, while the true cellular prevalence of cluster 2 is 1.
The estimates under SNV-based subclone callers do not fully recover the simulation truth. The main reason is probably that the phasing information of paired SNVs is lost in the marginal counts that are used in BayClone and PyClone, making the subclone estimation less accurate than under PairClone. For example, the two subclones with genotypes z (4) = (00, 11) and z (6) = (01, 10) lead to exactly the same allele frequency (50%) for both loci. BayClone can not distinguish between these two different subclones based on the 50% allele frequency for each locus. Although BayClone correctly reports the number of subclones, inference mistakenly includes a normal subclone with negligible weight, and thus fails to recover the true population frequencies. On the other hand, PyClone can not identify if cluster 2 contains homozygous (corresponding to cellular prevalence of 0.5) or heterozygous (corresponding to cellular prevalence of 1) variants. In contrast, using the phasing information, PairClone is able to infer two subclones having genotypes (00, 11) and (01, 10) for mutation pairs 11-30, and we know cluster 2 contains only heterozygous variants for sure.
A.3.2 Simulation 2
In the second simulation, we consider data with K = 100 mutation pairs and a more complicated subclonal structure with C TRUE = 4 latent subclones. We generate hypothetical data for T = 4 samples. The subclone matrix Z TRUE is shown in Figure A. 3(a).
Colors on a scale from light grey to red, to black (see the scale in the figure) are used to represent genotype z (q) with q = 1, . . . , 10. For example, subclone 4 has genotype z (10) for mutation pairs 1-20, z (5) for mutation pairs 21-40, z (8) for mutation pairs 41-60, z (1) for mutation pairs 61-80, and z (9) for mutation pairs 81-100. For each sample t, we generate the subclone proportions from a Dirichlet distribution, w TRUE t ∼ Dir(0.01, σ(20, 10, 5, 2)), where σ(20, 10, 5, 2) is a random permutation of (20, 10, 5, 2). The subclone proportion matrix w TRUE is shown in Figure A .3(b) , where darker blue color indicates higher abundance of a subclone in a sample, and light grey color represents low abundance. The parameters ρ TRUE and N tk are generated using the same approach as before, and we use v tk2 = v tk3 = 0.3 for k = 1, . . . , 50 and all t, and v tk2 = v tk3 = 0.35 for k = 51, . . . , 100 and all t. Finally, we calculate {p TRUE tkg } and generate read counts n tkg from equation (1) similar to previous simulation.
We fit the model with the same set of hyperparameters and MCMC parameters as in simulation 1. , even approximately. PyClone infers 8 clusters for the 200 loci, which reasonably recovers the truth. However, since the underlying subclone structure is more complex, the PyClone cellular prevalence is not directly comparable to PairClone outputs.
A.3.3 Simulation 3
In the last simulation we use T = 6 samples with C TRUE = 3 and latent subclones.
We still consider K = 100 mutation pairs. The subclone matrix Z TRUE is shown in Figure A .5(a). For each sample t, we generate the subclone proportions from w TRUE t ∼ Dir(0.01, σ(14, 6, 3)), where σ(14, 6, 3) is a random permutation of (14, 6, 3). The proportions w TRUE are shown in Figure A .5(b) . The parameters ρ TRUE and N tk are generated using the same approach as before, and we use the same v tk2 and v tk3 as in Simulation 2.
Finally, we calculate {p TRUE tkg } and generate read counts n tkg from equation (1) 
A.4 Simulation with tumor purity incorporated
We report simulation details of the simulation study with tumor purity incorporated in the manuscript (Section 5.2). The simulation setting is the same as simulation 3 in Section A.3.3, except that we substitute the first subclone with a normal subclone. We use exactly the same hyperparameters as those in simulations 2 and 3, and in addition we show that the effect of using p b is that p(C | n) is approximated by
where u = {π, w, ρ} are the parameters other than Z, u * is the maximum likelihood estimate of u, and p C is the number of unconstrained parameters in u. Importantly, however, inference on other parameters, p(x | C, n), remains entirely unchanged. We therefore recommend to focus on inference for C when calibrating b. Carrying out simulation studies with single and multi-sample data, we find that the simulation truth for C is best recovered with a test sample size (1 − b)
T t=1 K k=1 N tk ≈ 160/T , where N tk is the total number of short reads mapped to mutation pair k in sample t. For example, Figure A .8 plots the posterior mode of C against test sample sizes for simulated data in three simulations. For multi-sample data we find (empirically, by simulation) that the test sample size can be reduced, at a rate linear in T . In summary we recommend to set b to achieve a test sample size around 160/T . Following these guidelines, in our implementation in the previous section, we used values b = 0.992 for simulation 1, b = 0.9998 for simulation 2, and b = 0.999911 for simulation 3.
A.6 Lung Cancer Data Analysis Plots
We present two more plots for the lung cancer data analysis (manuscript Section 6). 
A.7 Validation of the MCMC scheme
Validation of the correctness of the sampler. We first use a scheme to validate the correctness of our MCMC sampler in the style of Geweke (2004) . The joint density of the parameters and observed data can be written as p(x, n) = p(x)p(n | x). Let g be any function g : X × N → R satisfying Var[g(x, n)] < ∞, where X and N represent sample spaces of x and n, respectively. Denote byḡ = E[g(x, n)], which can be evaluated by independent Monte Carlo simulation from the joint distribution, or in some cases might be known exactly as prior mean of functions of parameters only. Alternatively, the same mean can be estimated by a different Markov chain Monte Carlo scheme for the joint distribution, constructed by an initial draw
} is ergodic with unique invariant kernel p(x, n). If the simulator is error-free, one should have
whereŜ g (0) is consistent spectral density estimate for {g (l) , l = 1, . . . , L}. In our application, we take g(x, n) = w tc and p tkg . We set the number of samples T = 4, and the number of mutation pairs K = 80. Since our inference on C is not a standard MCMC, we fix C = 3 here and only consider x = {Z, π, w, ρ}. Convergence diagnostic. Next, we present some convergence diagnostics of our MCMC chain, including trace plots, autocorrelation plots, and test statistics described in Geweke (1991) . Those convergence diagnostics are based on the posterior distribution of param-
Let g be any function g : X → R, and g (l) = g(x (l) ) where
and letŜ
In our application, a reasonable choice of g is g(x) = p tkg (Z, w, ρ). We use simulation 2 as an example, and show some plots and Geweke's statistics for some randomly chosen p tkg . 
